Insider · CIK 0001430462

Khayal Tamer I

Reports to the SEC for 1 company · ANDOVER, MA

sec.gov

Transactions

Companies

Filings

CIK

0001430462

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-03-03	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−2,407 sh	$76.43	−$184K	36,042
2025-02-24	TMDXTransMedics Group, Inc.A Award	Chief Commercial Officer	AAward	+17.6K sh	—	—	38,449
2025-02-24	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+26.5K sh	—	—	26,499
2025-01-07	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,083 sh	$13.28	+$14.4K	21,926
2025-01-07	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−1,083 sh	$80.05	−$86.7K	20,843
2025-01-07	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,083 sh	—	—	15,167
2024-12-02	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,084 sh	$13.28	+$14.4K	21,927
2024-12-02	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−1,084 sh	$86.40	−$93.7K	20,843
2024-12-02	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,084 sh	—	—	16,250
2024-11-11	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,458 sh	$38.46	+$56.1K	22,301
2024-11-11	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−1,458 sh	$90.04	−$131K	20,843
2024-11-11	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,458 sh	—	—	5,834
2024-11-01	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,083 sh	$13.28	+$14.4K	21,926
2024-11-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−1,083 sh	$82.64	−$89.5K	20,843
2024-11-01	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,083 sh	—	—	17,334
2024-10-01	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,458 sh	$38.46	+$56.1K	22,301
2024-10-01	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+417 sh	$66.10	+$27.6K	22,718
2024-10-01	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,083 sh	$13.28	+$14.4K	23,801
2024-10-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−823 sh	$146.15	−$120K	22,978
2024-10-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−900 sh	$146.90	−$132K	22,078
2024-10-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−80 sh	$147.98	−$11.8K	21,998
2024-10-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−523 sh	$149.59	−$78.2K	21,475
2024-10-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−318 sh	$150.38	−$47.8K	21,157
2024-10-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−80 sh	$151.20	−$12.1K	21,077
2024-10-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−80 sh	$152.28	−$12.2K	20,997
2024-10-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−20 sh	$153.75	−$3,075	20,977
2024-10-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−134 sh	$154.86	−$20.8K	20,843
2024-10-01	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,458 sh	—	—	7,292
2024-10-01	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−417 sh	—	—	12,098
2024-10-01	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,083 sh	—	—	18,417
2024-09-03	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,459 sh	$38.46	+$56.1K	22,302
2024-09-03	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+417 sh	$66.10	+$27.6K	22,719
2024-09-03	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,084 sh	$13.28	+$14.4K	23,803
2024-09-03	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−599 sh	$157.27	−$94.2K	23,204
2024-09-03	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−921 sh	$158.09	−$146K	22,283
2024-09-03	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−132 sh	$159.02	−$21K	22,151
2024-09-03	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−396 sh	$160.67	−$63.6K	21,755
2024-09-03	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−700 sh	$161.54	−$113K	21,055
2024-09-03	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−80 sh	$163.09	−$13K	20,975
2024-09-03	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−32 sh	$164.68	−$5,269.76	20,943
2024-09-03	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−100 sh	$165.87	−$16.6K	20,843
2024-09-03	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,459 sh	—	—	8,750
2024-09-03	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−417 sh	—	—	12,515
2024-09-03	TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,084 sh	—	—	19,500
2024-08-01	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,458 sh	$38.46	+$56.1K	22,301
2024-08-01	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+417 sh	$66.10	+$27.6K	22,718
2024-08-01	TMDXTransMedics Group, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,083 sh	$13.28	+$14.4K	23,801
2024-08-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−114 sh	$151.80	−$17.3K	23,687
2024-08-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−154 sh	$152.71	−$23.5K	23,533
2024-08-01	TMDXTransMedics Group, Inc.S Sale	Chief Commercial Officer	SSale	−483 sh	$153.81	−$74.3K	23,050

Recent filings

Accepted (ET)
Mar 54
Khayal Tamer I0000950170-25-033706
SEC(opens sec.gov)
Feb 264
Khayal Tamer I0000950170-25-028040
SEC(opens sec.gov)
Jan 104
Khayal Tamer I0000950170-25-004192
SEC(opens sec.gov)
Dec 44
Khayal Tamer I0000950170-24-133392
SEC(opens sec.gov)
Nov 134
Khayal Tamer I0000950170-24-126397
SEC(opens sec.gov)
Nov 54
Khayal Tamer I0000950170-24-121525
SEC(opens sec.gov)
Oct 34
Khayal Tamer I0000950170-24-112394
SEC(opens sec.gov)

Companies

TransMedics Group, Inc.Chief Commercial OfficerTMDX

Address

C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD

ANDOVER, MA, 01810